Position in BIIB
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$964,707
+$152,556 QoQ
Shares Held
4,465
+0.8% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
#460
of 1,036 holders
Holding Since
Mar 2020
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BIIB Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026TWIN CAPITAL MANAGEMENT INC holds $51,361,248 across 9 Drug Manufacturers - General names. BIIB ranks #8 (1.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
15,076 | $18,082,608 | |
| 2 | JNJ |
Johnson & Johnson
|
47,173 | $11,980,526 | |
| 3 | AMGN |
Amgen Inc
|
15,782 | $5,714,977 | |
| 4 | MRK |
Merck & Co., Inc.
|
40,649 | $5,223,396 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
80,607 | $4,644,575 | |
| 6 | ABBV |
AbbVie Inc.
|
11,313 | $2,846,803 | |
| 7 | PFE |
Pfizer Inc
|
58,541 | $1,409,667 | |
| 8 | BIIB |
Biogen Inc.
This page
|
4,465 | $964,707 |
All Filings in BIIB
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $964,707 | 4,465 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $812,151 | 4,430 | Shares | Sole | 2026-05-05 | |
| 2025-09-30 | $950,863 | 6,788 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $1,511,350 | 12,034 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | $1,579,407 | 11,542 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $1,301,807 | 8,513 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $1,637,948 | 8,450 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $1,974,642 | 8,518 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $1,780,672 | 8,258 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $2,290,373 | 8,851 | Shares | Sole | 2024-01-31 | |
| 2023-09-30 | $2,346,244 | 9,129 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $2,752,505 | 9,663 | Shares | Sole | 2023-08-07 | |
| 2023-03-31 | $2,786,416 | 10,022 | Shares | Sole | 2023-05-08 | |
| 2022-12-31 | $3,206,733 | 11,580 | Shares | Sole | 2023-01-31 | |
| 2022-09-30 | $2,603,250 | 9,750 | Shares | Sole | 2022-10-21 | |
| 2021-09-30 | $437,785 | 1,547 | Shares | Sole | 2021-10-29 | |
| 2021-06-30 | $529,446 | 1,529 | Shares | Sole | 2021-08-09 | |
| 2021-03-31 | $427,737 | 1,529 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $3,140,819 | 12,827 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $3,748,831 | 13,215 | Shares | Sole | 2020-11-05 | |
| 2020-06-30 | $3,581,424 | 13,386 | Shares | Sole | 2020-08-04 | |
| 2020-03-31 | $4,533,409 | 14,329 | Shares | Sole | 2020-04-29 | |
| No filing history on record for this holder in this stock. | ||||||